Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005133 220002016 1.75 72.3 Palliative (P) 2016-04-11 2016-04-11 Cytarabine Low Dose N N 220027526 CYTARABINE
220005134 220015918 null 83 Curative (C) 2013-04-17 2013-04-23 AML17 TRIAL N N 220027534 AML17 TRIAL
220005135 220018722 null 78 Not known (9) 2014-10-21 2014-10-21 AML17 TRIAL N N 220027535 AML17 TRIAL
220005136 220020307 1.57 60.9 Curative (C) 2016-03-23 2016-03-23 AML17 TRIAL N N 220027538 AML17 TRIAL
220005137 220002017 1.67 73 Palliative (P) 2015-12-10 2015-12-11 Trial Unspecified Y N 220027543 TRIAL
220005138 220011067 1.59 76.2 Curative (C) 2014-11-14 2015-05-15 AML17 TRIAL N N 220027546 AML17 TRIAL
220005139 220011067 1.65 96.9 null 2013-01-07 2013-01-07 AML17 TRIAL Y null 220027546 AML17 TRIAL
220005140 220011067 1.82 70.8 Palliative (P) null 2015-08-10 CYTARABINE null null 220027546 CYTARABINE
220005141 220011067 1.63 null Curative (C) 2014-02-13 2014-02-23 Trial Unspecified N N 220027546 TRIAL
220005142 220011067 1.5 76 Curative (C) 2013-03-28 2013-03-28 Trial Unspecified 1 N 220027546 TRIAL
220005144 220002019 1.63 73.2 Curative (C) 2015-09-30 2015-09-30 LI-1 TRIAL Y N 220027553 TRIAL
220005145 220002019 1.52 80 Curative (C) 2017-03-20 2017-03-20 AML17 TRIAL Y N 220027553 AML17 TRIAL
220005146 220002020 null 147.9 Palliative (P) 2013-01-20 2013-01-20 Cytarabine Low Dose N N 220027555 CYTARABINE
220005147 220002020 1.61 77.7 Curative (C) 2013-03-06 2013-03-06 Trial Unspecified Y N 220027555 TRIAL
220005148 220002021 1.52 69.5 null 2013-01-21 2013-01-22 AML17 TRIAL 01 N 220027562 AML17 TRIAL
220005149 220002021 1.59 110.7 Palliative (P) null 2017-06-29 Cytarabine Low Dose N N 220027562 CYTARABINE
220005150 220002021 1.56 84 Curative (C) 2013-04-28 2013-04-29 Trial Unspecified Y N 220027562 TRIAL
220005151 220002021 1.68 90 Palliative (P) 2015-07-27 2015-07-27 Trial Unspecified 01 N 220027562 TRIAL
220005152 220002021 1.78 74.5 Disease modification (D) null 2013-03-18 LI-1 TRIAL N N 220027562 TRIAL
220005153 220002022 null 73.4 Not known (9) 2014-01-20 2014-01-20 Cytarabine Low Dose 02 N 220027577 CYTARABINE
220005154 220002022 1.8 66.4 Palliative (P) 2014-05-13 2014-05-14 Trial Unspecified 1 N 220027577 TRIAL
220005155 220002022 1.72 85 null 2013-05-31 2013-05-31 Cytarabine low (10to20mg/m2) IV/SC N N 220027577 CYTARABINE
220005156 220002022 null 69.5 Curative (C) 2014-06-26 2014-06-27 AML17 TRIAL 1 N 220027577 AML17 TRIAL
220005157 220002022 1.74 null Disease modification (D) 2013-12-12 2013-12-13 Cytarabine Low Dose 2 N 220027577 CYTARABINE
220005158 220002022 0 null null 2013-02-13 2013-02-24 Cytarabine Low Dose null N 220027577 CYTARABINE
220005159 220002023 1.73 null Curative (C) 2015-01-31 2015-01-31 Trial Unspecified Y N 220027588 TRIAL
220005160 220011072 1.74 null null 2017-12-06 2017-12-06 CYTARABINE 02 N 220027589 CYTARABINE
220005161 220011072 1.56 61 Not known (9) 2017-09-14 2017-09-20 AML17 TRIAL Y N 220027589 AML17 TRIAL
220005162 220002024 null 65 Disease modification (D) 2013-07-05 2013-07-06 CYTARABINE N N 220027591 CYTARABINE
220005163 220002024 1.62 null Curative (C) 2013-09-11 2013-09-11 AML17 TRIAL 01 N 220027591 AML17 TRIAL
220005164 220002025 null 85.699 Curative (C) 2013-02-07 2013-02-07 AML17 TRIAL Y N 220027594 AML17 TRIAL
220005165 220002025 1.53 114.5 Curative (C) 2013-08-27 2013-09-06 AML17 TRIAL N N 220027594 AML17 TRIAL
220005166 220002025 1.68 73 Curative (C) 2016-11-15 2016-11-15 Trial Unspecified Y N 220027594 TRIAL
220005167 220002025 1.85 null Curative (C) 2013-05-02 2013-05-02 Trial Unspecified 1 N 220027594 TRIAL
220005168 220002025 1.65 75 Not known (9) null 2013-11-25 Trial Unspecified Y N 220027594 TRIAL
220005169 220002026 null 74.5 Curative (C) 2017-05-05 2017-05-06 Trial Unspecified Y N 220027601 TRIAL
220005170 220002026 1.57 76.2 Palliative (P) 2014-04-17 2014-05-27 Cytarabine Low Dose 02 N 220027601 CYTARABINE
220005171 220002026 null 76.4 Curative (C) 2013-10-22 2013-10-23 Cytarabine low (10to20mg/m2) IV/SC N N 220027601 CYTARABINE
220005172 220002026 1.71 90.8 null 2016-01-11 2016-01-11 CYTARABINE 2 N 220027601 CYTARABINE
220005173 220002027 1.63 null Palliative (P) 2013-10-07 2013-10-07 Cytarabine Low Dose 2 N 220027609 CYTARABINE
220005174 220002028 1.83 null Palliative (P) 2014-03-31 2014-04-01 CYTARABINE 2 null 220027611 CYTARABINE
220005175 220011076 null 78.2 Curative (C) 2016-10-07 2016-10-08 Trial Unspecified 1 N 220027612 TRIAL
220005176 220011076 1.82 0 null 2017-07-24 2017-07-24 CYTARABINE N N 220027612 CYTARABINE
220005177 220011076 1.49 66 Curative (C) 2014-05-21 2014-05-21 Trial Unspecified null null 220027612 TRIAL
220005185 220002030 1.55 93.3 Palliative (P) 2017-11-21 2017-11-21 Cytarabine Low Dose N N 220027629 CYTARABINE
220005186 220002030 1.78 null Not known (9) 2014-06-09 2014-06-10 AML17 TRIAL 01 null 220027629 AML17 TRIAL
220005187 220002030 1.75 83 Not known (9) 2014-12-28 2015-01-08 Trial Unspecified Y N 220027629 TRIAL
220005189 220002032 1.55 null Palliative (P) 2016-05-16 2016-07-18 Cytarabine low (10to20mg/m2) IV/SC 2 null 220027642 CYTARABINE
220005192 220002033 0 null Curative (C) 2015-11-16 2015-11-17 Cytarabine Low Dose N N 220027648 CYTARABINE
220005193 220002033 1.63 null null 2017-09-11 2017-09-14 Cytarabine Low Dose 02 N 220027648 CYTARABINE